216 related articles for article (PubMed ID: 28643235)
1. Design and Evaluation of RGD-Modified Gemini Surfactant-Based Lipoplexes for Targeted Gene Therapy in Melanoma Model.
Mohammed-Saeid W; Chitanda J; Al-Dulaymi M; Verrall R; Badea I
Pharm Res; 2017 Sep; 34(9):1886-1896. PubMed ID: 28643235
[TBL] [Abstract][Full Text] [Related]
2. Design and Evaluation of Gemini Surfactant-Based Lipoplexes Modified with Cell-Binding Peptide for Targeted Gene Therapy in Melanoma Model.
Mohammed-Saeid W; Soudy R; Tikoo R; Kaur K; Verrall RE; Badea I
J Pharm Pharm Sci; 2018; 21(1):363-375. PubMed ID: 30266136
[TBL] [Abstract][Full Text] [Related]
3. Development of lyophilized gemini surfactant-based gene delivery systems: influence of lyophilization on the structure, activity and stability of the lipoplexes.
Mohammed-Saeid W; Michel D; El-Aneed A; Verrall RE; Low NH; Badea I
J Pharm Pharm Sci; 2012; 15(4):548-67. PubMed ID: 23106958
[TBL] [Abstract][Full Text] [Related]
4. Peptide-Modified Gemini Surfactants: Preparation and Characterization for Gene Delivery.
Al-Dulaymi M; Mohammed-Saeid W; El-Aneed A; Badea I
Methods Mol Biol; 2019; 2000():203-225. PubMed ID: 31148017
[TBL] [Abstract][Full Text] [Related]
5. How does the spacer length of cationic gemini lipids influence the lipoplex formation with plasmid DNA? Physicochemical and biochemical characterizations and their relevance in gene therapy.
Muñoz-Úbeda M; Misra SK; Barrán-Berdón AL; Datta S; Aicart-Ramos C; Castro-Hartmann P; Kondaiah P; Junquera E; Bhattacharya S; Aicart E
Biomacromolecules; 2012 Dec; 13(12):3926-37. PubMed ID: 23130552
[TBL] [Abstract][Full Text] [Related]
6. Transfection efficiencies of α-tocopherylated cationic gemini lipids with hydroxyethyl bearing headgroups under high serum conditions.
Maiti B; Kamra M; Karande AA; Bhattacharya S
Org Biomol Chem; 2018 Mar; 16(11):1983-1993. PubMed ID: 29498723
[TBL] [Abstract][Full Text] [Related]
7. Modulation of pyridinium cationic lipid-DNA complex properties by pyridinium gemini surfactants and its impact on lipoplex transfection properties.
Sharma VD; Lees J; Hoffman NE; Brailoiu E; Madesh M; Wunder SL; Ilies MA
Mol Pharm; 2014 Feb; 11(2):545-59. PubMed ID: 24377350
[TBL] [Abstract][Full Text] [Related]
8. Dicationic Amino Substituted Gemini Surfactants and their Nanoplexes: Improved Synthesis and Characterization of Transfection Efficiency and Corneal Penetration In Vitro.
Narsineni L; Foldvari M
Pharm Res; 2020 Jul; 37(7):144. PubMed ID: 32666411
[TBL] [Abstract][Full Text] [Related]
9. Transgene expression in mice of the Opa1 mitochondrial transmembrane protein through bicontinuous cubic lipoplexes containing gemini imidazolium surfactants.
Muñoz-Úbeda M; Semenzato M; Franco-Romero A; Junquera E; Aicart E; Scorrano L; López-Montero I
J Nanobiotechnology; 2021 Dec; 19(1):425. PubMed ID: 34922554
[TBL] [Abstract][Full Text] [Related]
10. Structural and transfection properties of amine-substituted gemini surfactant-based nanoparticles.
Wettig SD; Badea I; Donkuru M; Verrall RE; Foldvari M
J Gene Med; 2007 Aug; 9(8):649-58. PubMed ID: 17654656
[TBL] [Abstract][Full Text] [Related]
11. Physical Characterization of Gemini Surfactant-Based Synthetic Vectors for the Delivery of Linear Covalently Closed (LCC) DNA Ministrings.
Sum CH; Nafissi N; Slavcev RA; Wettig S
PLoS One; 2015; 10(11):e0142875. PubMed ID: 26561857
[TBL] [Abstract][Full Text] [Related]
12. Gemini surfactant dimethylene-1,2-bis(tetradecyldimethylammonium bromide)-based gene vectors: a biophysical approach to transfection efficiency.
Cardoso AM; Faneca H; Almeida JA; Pais AA; Marques EF; de Lima MC; Jurado AS
Biochim Biophys Acta; 2011 Jan; 1808(1):341-51. PubMed ID: 20937247
[TBL] [Abstract][Full Text] [Related]
13. In vivo cutaneous interferon-gamma gene delivery using novel dicationic (gemini) surfactant-plasmid complexes.
Badea I; Verrall R; Baca-Estrada M; Tikoo S; Rosenberg A; Kumar P; Foldvari M
J Gene Med; 2005 Sep; 7(9):1200-14. PubMed ID: 15895387
[TBL] [Abstract][Full Text] [Related]
14. Interactions between DNA and Gemini surfactant: impact on gene therapy: part I.
Ahmed T; Kamel AO; Wettig SD
Nanomedicine (Lond); 2016 Feb; 11(3):289-306. PubMed ID: 26785905
[TBL] [Abstract][Full Text] [Related]
15. Cellular Uptake and Distribution of Gemini Surfactant Nanoparticles Used as Gene Delivery Agents.
Jin W; Al-Dulaymi M; Badea I; Leary SC; Rehman J; El-Aneed A
AAPS J; 2019 Aug; 21(5):98. PubMed ID: 31388860
[TBL] [Abstract][Full Text] [Related]
16. The influence of novel gemini surfactants containing cycloalkyl side-chains on the structural phases of DNA in solution.
Pietralik Z; Kumita JR; Dobson CM; Kozak M
Colloids Surf B Biointerfaces; 2015 Jul; 131():83-92. PubMed ID: 25969417
[TBL] [Abstract][Full Text] [Related]
17. Interactions between DNA and gemini surfactant: impact on gene therapy: part II.
Ahmed T; Kamel AO; Wettig SD
Nanomedicine (Lond); 2016 Feb; 11(4):403-20. PubMed ID: 26784450
[TBL] [Abstract][Full Text] [Related]
18. Amino acid-substituted gemini surfactant-based nanoparticles as safe and versatile gene delivery agents.
Singh J; Yang P; Michel D; Verrall RE; Foldvari M; Badea I
Curr Drug Deliv; 2011 May; 8(3):299-306. PubMed ID: 21291379
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of cellular uptake and intracellular trafficking as determining factors of gene expression for amino acid-substituted gemini surfactant-based DNA nanoparticles.
Singh J; Michel D; Chitanda JM; Verrall RE; Badea I
J Nanobiotechnology; 2012 Feb; 10():7. PubMed ID: 22296763
[TBL] [Abstract][Full Text] [Related]
20. Effects of heterocyclic-based head group modifications on the structure-activity relationship of tocopherol-based lipids for non-viral gene delivery.
Gosangi M; Mujahid TY; Gopal V; Patri SV
Org Biomol Chem; 2016 Jul; 14(28):6857-70. PubMed ID: 27348545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]